114 related articles for article (PubMed ID: 1451052)
21. [High-dose leucovorin and 5-FU].
Sasaki T
Gan To Kagaku Ryoho; 1992 Jul; 19(7):954-62. PubMed ID: 1626951
[TBL] [Abstract][Full Text] [Related]
22. Calpain regulates thymidylate synthase-5-fluoro-dUMP complex levels associated with response to 5-fluorouracil in gastric cancer cells.
Nabeya Y; Suzuki T; Furuya A; Koide N; Ohkoshi M; Takiguchi M; Ochiai T; Matsubara H; Hiwasa T
Cancer Sci; 2011 Aug; 102(8):1509-15. PubMed ID: 21561529
[TBL] [Abstract][Full Text] [Related]
23. Does cisplatin (CDDP) function as a modulator of 5-fluorouracil (5-FU) antitumor action? A study based on a clinical trial.
Matsusaka S; Nagareda T; Yamasaki H
Cancer Chemother Pharmacol; 2005 Apr; 55(4):387-392. PubMed ID: 15647947
[TBL] [Abstract][Full Text] [Related]
24. [Effect of low-dose CDDP/5-FU therapy on thymidylate synthase content].
Kosaka T; Ueshige N; Sugaya J; Nakano Y; Takashima S
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():450-3. PubMed ID: 9589051
[TBL] [Abstract][Full Text] [Related]
25. Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.
Berne MH; Gustavsson BG; Almersjö O; Spears PC; Frösing R
Cancer Chemother Pharmacol; 1986; 16(3):237-42. PubMed ID: 3698165
[TBL] [Abstract][Full Text] [Related]
26. Effect of folinic acid on fluorouracil activity and expression of thymidylate synthase.
van der Wilt CL; Pinedo HM; Smid K; Cloos J; Noordhuis P; Peters GJ
Semin Oncol; 1992 Apr; 19(2 Suppl 3):16-25. PubMed ID: 1532671
[TBL] [Abstract][Full Text] [Related]
27. Enhanced inhibition of thymidylate synthase by 5-fluorouracil and [6S]leucovorin combination therapy for breast cancer.
Tominaga T; Toi M; Shirasaka T
Anticancer Res; 1993; 13(6B):2425-7. PubMed ID: 8135478
[TBL] [Abstract][Full Text] [Related]
28. A potential important role for thymidylate synthetase inhibition on antitumor activity of fluoropyrimidine and raltitexed.
Kabeshima Y; Kubota T; Watanabe M; Saikawa Y; Nishibori H; Hasegawa H; Kitajima M
Anticancer Res; 2002; 22(6A):3245-52. PubMed ID: 12530071
[TBL] [Abstract][Full Text] [Related]
29. 5-Fluorouracil and UFT-sensitive gastric carcinoma has a high level of thymidylate synthase.
Maehara Y; Kusumoto T; Kusumoto H; Anai H; Sakaguchi Y; Kido Y; Okamura T; Korenaga D; Sugimachi K
Cancer; 1989 May; 63(9):1693-6. PubMed ID: 2495166
[TBL] [Abstract][Full Text] [Related]
30. Roles of thymidylate synthase and dihydropyrimidine dehydrogenase in tumor progression and sensitivity to 5-fluorouracil in human gastric cancer.
Terashima M; Irinoda T; Fujiwara H; Nakaya T; Takagane A; Abe K; Yonezawa H; Oyama K; Inaba T; Saito K; Takechi T; Fukushima M
Anticancer Res; 2002; 22(2A):761-8. PubMed ID: 12014648
[TBL] [Abstract][Full Text] [Related]
31. Dihydropyrimidine dehydrogenase and messenger RNA levels in gastric cancer: possible predictor for sensitivity to 5-fluorouracil.
Ishikawa Y; Kubota T; Otani Y; Watanabe M; Teramoto T; Kumai K; Takechi T; Okabe H; Fukushima M; Kitajima M
Jpn J Cancer Res; 2000 Jan; 91(1):105-12. PubMed ID: 10744051
[TBL] [Abstract][Full Text] [Related]
32. Association of gastric and intestinal phenotypic marker expression of gastric carcinomas with tumor thymidylate synthase expression and response to postoperative chemotherapy with 5-fluorouracil.
Tajima Y; Shimoda T; Nakanishi Y; Yokoyama N; Tanaka T; Shimizu K; Saito T; Kawamura M; Kusano M; Kumagai K
J Cancer Res Clin Oncol; 2003 Dec; 129(12):683-90. PubMed ID: 14576935
[TBL] [Abstract][Full Text] [Related]
33. Thymidylate synthase and dihydropyrimidine dehydrogenase are related to histological effects of 5-fluorouracil and cisplatin neoadjuvant chemotherapy for primary gastric cancer patients.
Fukuda H; Takiguchi N; Koda K; Oda K; Seike K; Miyazaki M
Cancer Invest; 2006; 24(3):235-41. PubMed ID: 16809149
[TBL] [Abstract][Full Text] [Related]
34. UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner.
Hsueh CT; Kelsen D; Schwartz GK
Clin Cancer Res; 1998 Sep; 4(9):2201-6. PubMed ID: 9748140
[TBL] [Abstract][Full Text] [Related]
35. Antitumor activity of fluoropyrimidines and thymidylate synthetase inhibition.
Kubota T; Fujita S; Kodaira S; Yamamoto T; Josui K; Arisawa Y; Suto A; Ishibiki K; Abe O; Mabuchi K
Jpn J Cancer Res; 1991 Apr; 82(4):476-82. PubMed ID: 1904428
[TBL] [Abstract][Full Text] [Related]
36. Quantitative measurement of thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level in gastric cancer by real-time RT-PCR.
Fujiwara H; Terashima M; Irinoda T; Takagane A; Abe K; Kashiwaba M; Oyama K; Takahashi M; Maesawa C; Saito K; Takechi T; Fukushima M
Jpn J Cancer Res; 2002 Dec; 93(12):1342-50. PubMed ID: 12495474
[TBL] [Abstract][Full Text] [Related]
37. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
Johnston PG; Drake JC; Trepel J; Allegra CJ
Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
[TBL] [Abstract][Full Text] [Related]
38. [The role of thymidylate synthetase in sequential dose of MTX and 5-FU in the advanced scirrhous type gastric cancer].
Akazawa S; Yoshida K
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1273-8. PubMed ID: 2837988
[TBL] [Abstract][Full Text] [Related]
39. Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors.
Johnston PG; Lenz HJ; Leichman CG; Danenberg KD; Allegra CJ; Danenberg PV; Leichman L
Cancer Res; 1995 Apr; 55(7):1407-12. PubMed ID: 7882343
[TBL] [Abstract][Full Text] [Related]
40. Correlation between clinicopathologic factors and kinetics of metabolic enzymes for 5-fluorouracil given to patients with colon carcinoma by two different dosage regimens.
Katsumata K; Tomioka H; Sumi T; Yamashita S; Takagi M; Kato F; Nakamura R; Koyanagi Y; Aoki T; Kato K
Cancer Chemother Pharmacol; 2003 Feb; 51(2):155-60. PubMed ID: 12647017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
